endoscopic sclerotherapy

endoscopic sclerotherapy

The treatment of esophageal varices–EVs by endoscopic injection of a sclerosant–sodium tetradecyl sulfate into the veins; ES has been used to manage bleeding EVs; medical therapy may be more effective and have fewer complications, vis-à-vis control of active bleeding, prevent recurrences, and survival; ES may be equal or superior to other non-medical management–eg, insertion of a portacaval shunt, or selective splenorenal shunt for survival and preservation of liver function Complications Rebleeding–± 50%, esophageal ulceration, strictures, perforations, rebleeding, fever–40%, pulmonary and renal effects, and death in 1-2%. See Endoscopic ligation, Esophageal varices, Nadolol with isosorbide mononitrate.
References in periodicals archive ?
Endoscopic sclerotherapy affects the anastomotic compliance and thus delays gastric emptying in patients suffering from stoma dilation and post-RYGB weight gain.
Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy.
The endoscopic sclerotherapy, a technique that has been demonstrated in a review of cases series, can cause mucosal ulceration, stomal retraction, stenosis, and necrosis.
To know the effect of endoscopic sclerotherapy with absolute alcohol particularly in acute bleeding varices of different grades.
Secondary prophylaxis of esophageal variceal treatment: Endoscopic sclerotherapy, band ligation and combined therapy long-term results.
Since its introduction, endoscopic sclerotherapy of bleeding oesophageal varices, where variceal banding is not feasible, has remained the mainstay treatment for haemodynamically stable patients and where clotting abnormalities have been corrected.
Secondary Prophylaxis of Oesophageal Variceal Treatment: Endoscopic Sclerotherapy, Band Ligation and Combined Therapy--Long--Term, Results.
Endoscopic sclerotherapy for esophageal varices in children with extrahepatic portal venous obstruction: a follow up study.
Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics.
Endoscopic sclerotherapy has been investigated in these patients, but it is not recommended for primary prevention because it is associated with a high rate of adverse events.

Full browser ?